BG
CBST

BlackRock Group’s CUBIST PHARMACEUTICALS INC CBST Stock Holding History

BlackRock Group’s Portfolio CBST Stock Details CBST Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2015
Q1 		– Sell
-45,096
Closed -$4.54M – 2960
2014
Q4 		$4.54M Sell
45,096
-319,908
-88% -$24.9M ﹤0.01% 1148
2014
Q3 		$24.2M Buy
365,004
+87,800
+32% +$5.77M 0.01% 736
2014
Q2 		$19.4M Buy
277,204
+6,677
+2% +$454K 0.01% 802
2014
Q1 		$19.8M Buy
270,527
+34,498
+15% +$2.57M 0.01% 775
2013
Q4 		$16.3M Buy
236,029
+2,872
+1% +$186K 0.01% 809
2013
Q3 		$14.8M Sell
233,157
-19,364
-8% -$1.17M 0.01% 831
2013
Q2 		$12.2M Buy
+252,521
New +$12.4M 0.01% 808

BlackRock Group's CBST Position: Q1 2015 in Review

BlackRock Group sold out of CUBIST PHARMACEUTICALS INC (CBST) in Q1 2015, closing a stake of 45,096 shares — an estimated $4.54M sold.

BlackRock Group first reported a position in CBST in Q2 2013 and held it in 7 quarters. The position peaked at $24.2M in Q3 2014. 0 funds tracked by Wall St. Rank hold CBST as of Q1 2015.

  • BlackRock Group reported no remaining CUBIST PHARMACEUTICALS INC position as of Q1 2015 after selling out during the quarter.
  • BlackRock Group sold 45,096 CUBIST PHARMACEUTICALS INC shares in Q1 2015, an estimated $4.54M.
  • BlackRock Group first reported a position in CUBIST PHARMACEUTICALS INC in Q2 2013 and held it in 7 quarters.
  • BlackRock Group's CUBIST PHARMACEUTICALS INC position peaked at $24.2M in Q3 2014.
  • 0 funds tracked by Wall St. Rank held CUBIST PHARMACEUTICALS INC as of Q1 2015.

Based on BlackRock Group's 13F filing for Q1 2015, filed 13 May 2015.